Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Series B brings in $43mm for CNS start-up NeuroTherapeutics
21 May 2010
First-time investors MPM Capital and SR One have co-led the $43mm Series B financing for NeuroTherapeutics Pharma Inc. (diseases caused by a hyperexcitable central nervous system). Fidelity Biosciences and Pfizer Venture Investments, other new backers, also participated along with returning shareholders Novo Ventures and Thomas McNerney & Partners. All of the new investors have contributed board members to the company.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?